1 – 17 of 17
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
National long-term patient-reported outcomes following mastectomy with or without breast reconstruction : The Swedish Breast Reconstruction Outcome Study Part 2 (SweBRO 2)
(
- Contribution to journal › Article
- 2023
-
Mark
Prevalence of women with breast implants in Sweden : a study based on the population-based mammography screening programme
(
- Contribution to journal › Article
-
Mark
Proteogenomics decodes the evolution of human ipsilateral breast cancer
(
- Contribution to journal › Article
- 2021
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
(
- Contribution to journal › Article
- 2020
-
Mark
Survival after primary breast cancer surgery following propofol or sevoflurane general anesthesia—A retrospective, multicenter, database analysis of 6305 Swedish patients
(
- Contribution to journal › Article
-
Mark
Breast reconstruction patterns from a Swedish nation-wide survey
(
- Contribution to journal › Article
-
Mark
LGR5 in breast cancer and ductal carcinoma in situ : a diagnostic and prognostic biomarker and a therapeutic target
(
- Contribution to journal › Article
- 2019
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
(
- Contribution to journal › Article
-
Mark
Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
(
- Contribution to journal › Article
- 2018
-
Mark
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors
(
- Contribution to journal › Article
-
Mark
A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk
2018) In Clinical cancer research : an official journal of the American Association for Cancer Research 24(23). p.5895-5901(
- Contribution to journal › Article
- 2015
-
Mark
The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
(
- Contribution to journal › Article
- 2014
-
Mark
The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy.
(
- Contribution to journal › Article
-
Mark
Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial.
(
- Contribution to journal › Article
- 2013
-
Mark
A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.
(
- Contribution to journal › Article
-
Mark
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
(
- Contribution to journal › Article
- 2010
-
Mark
Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
(
- Contribution to journal › Article